Bayer AG (WBO:BAYN) Cash Flow for Dividends: €-127 Mil (TTM As of Mar. 2026)


WBO:BAYN Bayer AG WBO:BAYN
57 GF Score
Price €47.18
GF Value €27.30
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Bayer AG Cash Flow for Dividends?

Bayer AG WBO:BAYN +18.69% 57 Cash Flow for Dividends is €-127 Mil as of Mar. 2026. GuruFocus rates WBO:BAYN with a GF Score™ of 57/100 and a GF Value™ of €27.30 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Bayer AG's cash flow for dividends for the three months ended in Mar. 2026 was €0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was €-127 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Bayer AG's quarterly payment of dividends increased from Sep. 2025 (€-8 Mil) to Dec. 2025 (€-11 Mil) but then declined from Dec. 2025 (€-11 Mil) to Mar. 2026 (€0 Mil).

Bayer AG's annual payment of dividends declined from Dec. 2023 (€-2,379 Mil) to Dec. 2024 (€-131 Mil) and declined from Dec. 2024 (€-131 Mil) to Dec. 2025 (€-127 Mil).

Bayer AG Cash Flow for Dividends Related Terms

Bayer AG Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Bayer AG's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer AG Cash Flow for Dividends Chart

Bayer AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,993.00 -1,985.00 -2,379.00 -131.00 -127.00

Bayer AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -108.00 -8.00 -11.00 0.00
WBO:BAYN
57GF Score
Bayer AG WBO:BAYN
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bayer AG Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-127 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of €-127 Mil mean?
Bayer AG (WBO:BAYN) has a Cash Flow for Dividends of €-127 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Bayer AG and its competitors.
Is Bayer AG's Cash Flow for Dividends too high?
Bayer AG's current Cash Flow for Dividends is €-127 Mil. Overall, Bayer AG has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bayer AG's Cash Flow for Dividends compare to LLY and JNJ?
Bayer AG's Cash Flow for Dividends of €-127 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Bayer AG and its competitors. Bayer AG's current Cash Flow for Dividends is €-127 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayer AG stock overvalued right now?
Based on GuruFocus' analysis, Bayer AG (WBO:BAYN) is currently considered Significantly Overvalued. The stock's GF Value™ is €27.30, compared to a current price of €47.18 — trading 72.8% above its estimated fair value. The current Cash Flow for Dividends is €-127 Mil. Bayer AG's overall GF Score™ is 57/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Bayer AG (WBO:BAYN), the current Cash Flow for Dividends is €-127 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bayer AG (WBO:BAYN) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of €47.18 is trading 72.8% above its estimated GF Value™ of €27.30. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for WBO:BAYN:

  • Cash Flow for Dividends: €-127 Mil
  • GF Value™: €27.30 vs. price of €47.18 (72.8% above fair value)
  • GF Score™: 57/100 with 2 warning signs

No single metric tells the full story. See the WBO:BAYN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
57GF Score

Get the complete analysis for WBO:BAYN

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€47.18
Price
€27.30
GF Value